PROSENSA TECHNOLOGIES B.V.
Patent Owner
Stats
- 0 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Aug 07, 2014 most recent publication
Details
- 0 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 330 Total Citation Count
- Jan 05, 2005 Earliest Filing
- 9 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
- No Technology to Display
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
- No Recent Patents to Display
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2014/0221,458 METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNAAbandonedMar 07, 14Aug 07, 14[C12N]
2014/0128,592 METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNAAbandonedDec 19, 13May 08, 14[C12N]
2014/0113,955 METHODS AND MEANS FOR EFFICIENT SKIPPING OF EXON 45 IN DUCHENNE MUSCULAR DYSTROPHY PRE-mRNAAbandonedDec 04, 13Apr 24, 14[C12N]
2011/0229,552 NOVEL mRNA SPLICE VARIANT OF THE DOUBLECORTIN-LIKE KINASE GENE AND ITS USE IN DIAGNOSIS AND THERAPY OF CANCERS OF NEUROECTODERMAL ORIGINAbandonedJan 23, 07Sep 22, 11[A61K, C07H, C12Q, C12N, G01N, A61P]
2011/0020,430 Novel mRNA splice variant of the doublecortin-like kinase gene and its use in cancer diagnosis and therapyAbandonedMay 24, 10Jan 27, 11[A61K, A61P]
7754871 mRNA splice variant of the doublecortin-like kinase gene and its use in cancer diagnosis and therapyExpiredJul 22, 05Jul 13, 10[C07H, A61K]
2006/0148,740 Mannose-6-phosphate receptor mediated gene transfer into muscle cellsAbandonedJan 05, 05Jul 06, 06[A61K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.